Evaluation of the Next Generation WATCHMAN LAA Closure Technology in Non-Valvular AF Patients (EVOLVE)

NCT01196897 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DEVICE: WATCHMAN LAA Closure Technology (Gen 4.0)

Sponsor

Boston Scientific Corporation